13F Pro Quality Score

38.4/100

Rank #2,008 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

22.6/100

Profitability

20.2/100

Balance Sheet

24.6/100

Earnings Quality

30.0/100

Free Cash Flow

54.3/100

Institutional Flow

17.4/100

Revenue Scale

81.9/100

Dilution Risk

66.8/100

AVTR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Avantor, Inc. (AVTR), a Technology sector company. 13F Pro's AI-powered ranking engine scores AVTR at 38.4/100 on a 32-signal composite quality model, placing it at rank #2,008 of 2,879 stocks — the bottom half of the AI-ranked universe. AVTR scores in the top quartile across revenue scale (81.9). Areas of concern include institutional flow (17.4) and profitability (20.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Avantor, Inc. reports quarterly revenue of $1.6B, net income of $43.3M, free cash flow of $25.2M. Top institutional holders of AVTR by reported 13-F value include DODGE & COX, BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. AVTR trades on the NYSE exchange and files with the SEC under CIK 1722482. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVTR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Avantor, Inc. directly from SEC EDGAR. Avantor, Inc.'s 13F Pro composite quality score has ranged between 8 and 66 since 2021, currently 38.4 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about Avantor, Inc.

Quirks, history, and lore behind AVTR — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. life sciences company · large-cap · listed on the NYSE · headquartered in Pennsylvania.
  • 2
    The Numbers
    Annual revenue of roughly $7 billion, serving over 300,000 customer locations across biopharma, healthcare, and advanced technology industries worldwide.
  • 3
    The History
    Traces its roots to a chemicals and lab supplies distributor founded decades ago; it was later carved out and taken public in 2019 in one of the larger IPOs that year.
  • 4
    The Secret
    It doesn't make drugs — it makes the ultra-high-purity materials and consumables that drugmakers can't live without, essentially the picks-and-shovels of the biotech gold rush.
  • 5
    The Lore
    The company operates a sprawling production and distribution network spanning roughly 30 countries, keeping some of the world's most demanding laboratory scientists reliably stocked.
  • 6
    The Giveaway
    Its ticker is a near-anagram of its name, and that name — a mashup of "advanced" and "avant-garde" — hints at its mission: supplying mission-critical materials to science's cutting edge.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$1.6B

Net Income

Q1 2026

$43.3M

Free Cash Flow

Q1 2026

$25.2M

D/E Ratio

Q1 2026

0.69

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-9.7% YoY
$6.78BFY 2024
FY19 $6.04BFY20 $6.39BFY22 $7.51BFY24 $6.78B

Net Income

+3.6% YoY
$711.5MFY 2024
FY19 $37.8MFY20 $116.6MFY22 $686.5MFY24 $711.5M

Operating Income

-4.0% YoY
$1.08BFY 2024
FY19 $551.8MFY20 $706.8MFY22 $1.13BFY24 $1.08B

EPS (Diluted)

+3.0% YoY
$1.04FY 2024
FY19 $-0.84FY20 $0.09FY22 $1.01FY24 $1.04

Total Assets

-10.0% YoY
$12.11BFY 2024
FY19 $9.77BFY20 $9.91BFY22 $13.46BFY24 $12.11B

Total Debt

-26.7% YoY
$4.88BFY 2024
FY19 $5.21BFY20 $4.92BFY22 $6.65BFY24 $4.88B

Op. Cash Flow

-0.3% YoY
$840.8MFY 2024
FY19 $354.0MFY20 $929.8MFY22 $843.6MFY24 $840.8M

Get alerted when AVTR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Avantor, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of AVTR

Put AVTR on your watchlist

Track score changes the day Avantor, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AVTR a good stock to buy?

13F Pro's AI-powered analysis of Avantor, Inc. (AVTR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AVTR are available on the AVTR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AVTR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AVTR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Avantor, Inc.'s investment landscape.